Skip to main content

Billions are spent treating Parkinson's Disease each year. Not only would a cure be of immense benefit to society, but it would make the company involved billions.

Here are the public companies

closest to a cure/treatment.

Remember Erin Brockovich? Well, now she's an executive at a

micro-cap public company


Time to analyze the

52-week-low list

where often the bargains can be found.

This is the best analysis of

brand value I've seen

. I now finally understand what it means (or should mean) when someone says


(GOOG) - Get Alphabet Inc. Class C Report

has a more valuable brand than

Coca Cola

TheStreet Recommends

(KO) - Get Coca-Cola Company Report


Jeremy Siegel shares some

Buffett wisdom


Dealbreaker breaks down


(T) - Get AT&T Inc. Report

CEO Whitacre's pay


Here are Stockpickr's

latest activist situations

, where hedge funds are clamoring to unlock value in deep-value situations. Today's list includes


(NLS) - Get Nautilus Inc Report


Flow International

(FLOW) - Get SPX Flow, Inc. Report

, as well as homebuilder

Beazer Homes

(BZH) - Get Beazer Homes USA, Inc. Report


It was

65 years ago today


Top 10 Small-Cap Value Plays


The options tell the whole story. Counting down an

FDA decision





Finally, can

XM Satellite Radio

( XMSR) and


(SIRI) - Get Sirius XM Holdings, Inc. Report

hit bottom?

What's the sum of the parts if

General Electric

(GE) - Get General Electric Company Report

breaks up


Notable Calls thinks

MEMC Electronic Materials


might be

a bounce play here


The Stockmasters have some thoughts about what you should do with your money if you believe in "

sell in May and go away


Hmm, is this even a possibility? Can

Google buy NBC


And if you missed it,

Cramer's Portfolios of the week


Please note that due to factors including low market capitalization and/or insufficient public float, we consider Nautilus, Flow International and Dendreon to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.

At the time of publication, Altucher and/or his fund had no positions in the stocks mentioned, although positions may change at any time.

James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of

Trade Like a Hedge Fund


Trade Like Warren Buffett

. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;

click here

to send him an email. has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from